Methaqualone (MQL) antibody and antigen (hapten, BSA/OVA conjugated)

Diagnostic anti-Methaqualone (MQL) antibodies (anti-Methaqualone, anti-MQL) and diagnostic hapten-carrier conjugates BSA-Methaqualone (MQL), OVA-Methaqualone (MQL), KLH-Methaqualone (MQL) antigens for Pain MQL detection in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.

Target products collectionGo to Neurodegenerative diseases diagnostics products collection >>


Product information

Catalog No. Description US $ Price (per mg)
GMP-SMT-238-Ag01 BSA-Methaqualone (MQL) 756
GMP-SMT-238-Ag02 OVA-Methaqualone (MQL) 756
GMP-SMT-238-Ab01 Anti-human Methaqualone (MQL) mouse monoclonal antibody (mAb) 1953
GMP-SMT-238-Ab02 Anti-human Methaqualone (MQL) human monoclonal antibody (mAb) 1953

Size: 1mg | 10mg | 100mg



Product Description

Cat No. of Products GMP-SMT-238-Ag01
Product Name BSA-Methaqualone (MQL)
Target/Biomarker Methaqualone (MQL)
Expression platform Synthetic
Isotypes NA
Bioactivity validation Methaqualone (MQL) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in MQL level test of Pain () and related syndrome evaluation.
Tag NA
Products description Competitive immunoassay-validated hapten-carrier conjugates BSA-Methaqualone (MQL) / OVA-Methaqualone (MQL) is Synthetic.
Purity Purity: ≥95% (SDS-PAGE)
Application Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-SMT-238-Ag02
Product Name OVA-Methaqualone (MQL)
Target/Biomarker Methaqualone (MQL)
Expression platform Synthetic
Isotypes NA
Bioactivity validation Methaqualone (MQL) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in MQL level test of Pain () and related syndrome evaluation.
Tag NA
Products description Competitive immunoassay-validated hapten-carrier conjugates BSA-Methaqualone (MQL) / OVA-Methaqualone (MQL) is Synthetic.
Purity Purity: ≥95% (SDS-PAGE)
Application Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-SMT-238-Ab01
Product Name Anti-human Methaqualone (MQL) mouse monoclonal antibody (mAb)
Target/Biomarker Methaqualone (MQL)
Expression platform Hybridoma
Isotypes Mouse IgG
Bioactivity validation Methaqualone (MQL) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in MQL level test of Pain () and related syndrome evaluation.
Tag mFc
Products description Competitive immunoassay-validated hapten-carrier conjugates BSA-Methaqualone (MQL) / OVA-Methaqualone (MQL) is Synthetic.
Purity Purity: ≥95% (SDS-PAGE)
Application Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-SMT-238-Ab02
Product Name Anti-human Methaqualone (MQL) human monoclonal antibody (mAb)
Target/Biomarker Methaqualone (MQL)
Expression platform Hybridoma
Isotypes Mouse IgG
Bioactivity validation Methaqualone (MQL) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in MQL level test of Pain () and related syndrome evaluation.
Tag mFc
Products description Competitive immunoassay-validated hapten-carrier conjugates BSA-Methaqualone (MQL) / OVA-Methaqualone (MQL) is Synthetic.
Purity Purity: ≥95% (SDS-PAGE)
Application Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker information

    1. Methaqualone in In Vitro Diagnosis (IVD): An In-Depth Exploration Methaqualone, a distinctive small molecule with significant clinical implications, assumes a critical role within the realm of in vitro diagnosis (IVD). In this comprehensive elucidation, we delve into the multifaceted role of Methaqualone in IVD, uncovering its indispensable applications, methodological intricacies, and the profound rationale behind its precise measurement. The intricate relationship between Methaqualone and IVD unfolds as we explore its diverse applications and the scientific foundations that underpin its indispensability. 2. The Pivotal Role of Methaqualone in Diagnostic Assays Methaqualone serves as a linchpin in the development of diagnostic assays within IVD. Collaboratively employed with our specialized anti-small molecules antibodies and small molecules competitive antigens, Methaqualone empowers precise, specific, and quantitative detection of antibodies or immune responses directed against it. This strategic synergy forms the bedrock of IVD, enabling the identification and quantification of Methaqualone-related phenomena with unparalleled accuracy. 3. Clinical Surveillance and Methaqualone Measurement Within the clinical landscape, the measurement of Methaqualone emerges as a matter of paramount importance. Methaqualone, a sedative-hypnotic medication with potential for misuse, demands vigilant monitoring. Routine measurement of Methaqualone levels within patient samples becomes a critical tool for surveillance, enabling the identification of individuals engaged in potentially harmful misuse. This surveillance is pivotal for early intervention, patient management, and the mitigation of potential health risks linked to Methaqualone misuse. 4. Forensic and Workplace Testing The significance of Methaqualone measurement extends beyond clinical settings to encompass forensic and workplace environments. Methaqualone is frequently featured as a target analyte in drug testing programs, necessitating verification of recent usage. The measurement of Methaqualone in these contexts is foundational for identifying individuals who have used this substance, ensuring compliance with regulatory requirements, and upholding organizational policies concerning substance use. 5. Treatment Monitoring and Rehabilitation In clinical practice, the measurement of Methaqualone plays a pivotal role in monitoring patients undergoing addiction treatment or rehabilitation. Methaqualone addiction poses a significant challenge, with patients at risk of relapse. Methaqualone measurement empowers healthcare providers to ascertain treatment adherence and abstinence, facilitating tailored interventions when necessary. This optimization enhances the prospects of successful rehabilitation and recovery. 6. Personalized Medicine and Pharmacokinetics A profound understanding of Methaqualone's pharmacokinetics is fundamental to the principles of personalized medicine. Quantifying Methaqualone levels within patient samples enables healthcare providers to customize treatment plans according to individual patient needs. This precision medicine approach not only enhances therapeutic outcomes but also mitigates potential side effects or adverse reactions associated with suboptimal dosing. 7. Scientific Research and Advancements Beyond clinical and forensic applications, Methaqualone measurement serves as a valuable asset in the realm of scientific research. Researchers leverage insights from Methaqualone measurement to advance our understanding of this substance's pharmacological properties, its effects on the human body, and potential treatments for Methaqualone addiction. This research transcends clinical boundaries, contributing to broader discoveries in the healthcare field and substance abuse science. 8. Conclusion: The Comprehensive Significance of Methaqualone Measurement in IVD In conclusion, the measurement of Methaqualone within the context of in vitro diagnosis transcends its role as a diagnostic tool. It emerges as a linchpin in clinical surveillance, forensic and workplace testing, addiction treatment, personalized medicine, and scientific research. This comprehensive significance underscores its pivotal role in advancing healthcare outcomes, public safety, and our understanding of substance abuse. Methaqualone measurement remains at the forefront of IVD, shaping the future of healthcare in multifaceted ways.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.

    Comments


    No comments yet.

    Leave a comment